The US and the Afghan Taliban have made "significant progress" in talks aimed at ending the 17-year-old conflict in Afghanistan, the US envoy has said. In a series of tweets, Zalmay Khalilzad did not give details but said the unprecedented six days of talks in Qatar were "more productive than they have been in the past". He said he was on his way to Kabul to consult Afghan government officials. Earlier, Taliban sources said the two sides had finalised a draft agreement. The deal calls for a withdrawal of foreign forces in return for assurances that al-Qaeda and the Islamic State (IS) group will not be allowed to use Afghanistan as a base, the sources said. Mr Khalilzad said talks with the Taliban would continue and that nothing had been finalised. Skip Twitter post by @US4AfghanPeace Report End of Twitter post by @US4AfghanPeace The Taliban has so far refused to hold direct talks with Afghan officials, whom they dismiss as "puppets". They
The World Health Organisation (WHO) has said that a new drug – Carbetocin – has the potential to save thousands of women’s lives annually. WHO said Carbetocin now serves as a new competition – with improved benefits – to Oxytocin, a stand-by drug used to prevent potentially-fatal bleeding after childbirth. WHO said excessive bleeding after childbirth still kills around 70,000 mothers a year and currently, Oxytocin is the first-choice medication, but it must be kept cold, unlike the new drug, Carbetocin. The study, partly led, among others, by WHO and published on Wednesday, suggested that the new drug which could be stored at normal temperatures, could save the lives of thousands in low- and lower-middle-income countries. “This is a truly encouraging new development that can revolutionise our ability to keep mothers and babies alive,” said WHO Director-General Tedros Adhanom Ghebreyesus. Read more